Role of interventional oncology in hepatocellular carcinoma: Future best practice beyond current guidelines.

ABSTRACT: Hepatocellular carcinoma (HCC) is a leading cause of cancer-related deaths globally. Liver transplant remains the goal of curative treatment, but limited supply of organs decreases accessibility and prolongs waiting time to transplantation. Therefore, interventional oncology therapies have been used to treat the majority of HCC patients, including those awaiting transplant. The Barcelona Clinic Liver Cancer (BCLC) classification is the most widely used staging system in management of HCC that helps allocate treatments. Since its inception in 1999, it was updated for the fifth time in November 2021 and for the first time shaped by expert opinions outside the core BCLC group. The most recent version includes additional options for early-stage disease, substratifies intermediate disease into

SUBMITTER: Goyal P 

PROVIDER: S-EPMC9815732 | biostudies-literature | 2022 Sep

REPOSITORIES: biostudies-literature